220 related articles for article (PubMed ID: 9990418)
1. Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life.
Grosshans E; Marks R; Mascaro JM; Torras H; Meynadier J; Alirezai M; Finlay AY; Soto P; Poncet M; Verschoore M; Clucas A
Br J Dermatol; 1998 Oct; 139 Suppl 52():26-33. PubMed ID: 9990418
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial.
Shalita A; Weiss JS; Chalker DK; Ellis CN; Greenspan A; Katz HI; Kantor I; Millikan LE; Swinehart T; Swinyer L; Whitmore C; Baker M; Czernielewski J
J Am Acad Dermatol; 1996 Mar; 34(3):482-5. PubMed ID: 8609263
[TBL] [Abstract][Full Text] [Related]
3. Adapalene 0.1% gel for the treatment of acne vulgaris: its superiority compared to tretinoin 0.025% cream in skin tolerance and patient preference.
Dunlap FE; Mills OH; Tuley MR; Baker MD; Plott RT
Br J Dermatol; 1998 Oct; 139 Suppl 52():17-22. PubMed ID: 9990416
[TBL] [Abstract][Full Text] [Related]
4. Comparison of adapalene 0.1% solution and tretinoin 0.025% gel in the topical treatment of acne vulgaris.
Ellis CN; Millikan LE; Smith EB; Chalker DM; Swinyer LJ; Katz IH; Berger RS; Mills OH; Baker M; Verschoore M; Loesche C
Br J Dermatol; 1998 Oct; 139 Suppl 52():41-7. PubMed ID: 9990420
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials.
Cunliffe WJ; Poncet M; Loesche C; Verschoore M
Br J Dermatol; 1998 Oct; 139 Suppl 52():48-56. PubMed ID: 9990421
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study of the efficacy and tolerability of 0.1 and 0.03 p.100 adapalene gel and 0.025 p.100 tretinoin gel in the treatment of acne].
Alirezai M; Meynadier J; Jablonska S; Czernielewski J; Verschoore M
Ann Dermatol Venereol; 1996; 123(3):165-70. PubMed ID: 8761775
[TBL] [Abstract][Full Text] [Related]
7. Randomised, controlled trial of the efficacy and safety of adapalene gel 0.1% and tretinoin cream 0.05% in patients with acne vulgaris.
Cunliffe WJ; Danby FW; Dunlap F; Gold MH; Gratton D; Greenspan A
Eur J Dermatol; 2002; 12(4):350-4. PubMed ID: 12095880
[TBL] [Abstract][Full Text] [Related]
8. Adapalene 0.1% gel is better tolerated than tretinoin 0.025% gel in acne patients.
Clucas A; Verschoore M; Sorba V; Poncet M; Baker M; Czernielewski J
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 2):S116-8. PubMed ID: 9204089
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris.
Thiboutot D; Gold MH; Jarratt MT; Kang S; Kaplan DL; Millikan L; Wolfe J; Loesche C; Baker M
Cutis; 2001 Oct; 68(4 Suppl):10-9. PubMed ID: 11845943
[TBL] [Abstract][Full Text] [Related]
10. A comparison of adapalene gel 0.1% vs. tretinoin gel 0.025% in the treatment of acne vulgaris in China.
Tu P; Li GQ; Zhu XJ; Zheng J; Wong WZ
J Eur Acad Dermatol Venereol; 2001; 15 Suppl 3():31-6. PubMed ID: 11843231
[TBL] [Abstract][Full Text] [Related]
11. A comparative trial of two retinoids commonly used in the treatment of acne vulgaris.
Nyirady J; Grossman RM; Nighland M; Berger RS; Jorizzo JL; Kim YH; Martin AG; Pandya AG; Schulz KK; Strauss JS
J Dermatolog Treat; 2001 Sep; 12(3):149-57. PubMed ID: 12243706
[TBL] [Abstract][Full Text] [Related]
12. Split-face comparison of adapalene 0.1% gel and tretinoin 0.025% gel in acne patients.
Caron D; Sorba V; Kerrouche N; Clucas A
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 2):S110-2. PubMed ID: 9204087
[TBL] [Abstract][Full Text] [Related]
13. Split-face clinical and bio-instrumental comparison of 0.1% adapalene and 0.05% tretinoin in facial acne.
Piérard-Franchimont C; Henry F; Fraiture AL; Fumal I; Piérard GE
Dermatology; 1999; 198(2):218-22. PubMed ID: 10325486
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of CD 271 alcoholic gels in the topical treatment of acne vulgaris.
Verschoore M; Langner A; Wolska H; Jablonska S; Czernielewski J; Schaefer H
Br J Dermatol; 1991 Apr; 124(4):368-71. PubMed ID: 1827344
[TBL] [Abstract][Full Text] [Related]
15. Topical adapalene gel 0.1% vs. isotretinoin gel 0.05% in the treatment of acne vulgaris: a randomized open-label clinical trial.
Ioannides D; Rigopoulos D; Katsambas A
Br J Dermatol; 2002 Sep; 147(3):523-7. PubMed ID: 12207595
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and U.S. multicenter trials.
Cunliffe WJ; Caputo R; Dreno B; Förström L; Heenen M; Orfanos CE; Privat Y; Robledo Aguilar A; Meynadier J; Alirezai M; Jablonska S; Shalita A; Weiss JS; Chalker DK; Ellis CN; Greenspan A; Katz HI; Kantor I; Millikan LE; Swinehart JM; Swinyer L; Whitmore C; Czernielewski J; Verschoore M
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 2):S126-34. PubMed ID: 9204091
[TBL] [Abstract][Full Text] [Related]
17. Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate and Severe Acne Vulgaris in Females: Effect of Age on Efficacy and Tolerability.
Stein Gold L; Pariser DM; Guenin E
J Drugs Dermatol; 2019 Dec; 18(12):1218-1225. PubMed ID: 31860209
[TBL] [Abstract][Full Text] [Related]
18. Topical tretinoin or adapalene in acne vulgaris: an overview.
Jain S
J Dermatolog Treat; 2004 Jul; 15(4):200-7. PubMed ID: 15764031
[TBL] [Abstract][Full Text] [Related]
19. Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study.
Stein Gold L; Weiss J; Rueda MJ; Liu H; Tanghetti E
Am J Clin Dermatol; 2016 Jun; 17(3):293-303. PubMed ID: 26945741
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of adapalene gel 0.1% and 0.3% and tretinoin gel 0.05% for acne vulgaris: results of a single-center, randomized, double-blinded, placebo-controlled clinical trial on Mexican patients (skin type III-IV).
Tirado-Sánchez A; Espíndola YS; Ponce-Olivera RM; Bonifaz A
J Cosmet Dermatol; 2013 Jun; 12(2):103-7. PubMed ID: 23725303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
